Blunted or impeded therapeutic response to vitamin B12 may be due to such conditions as infection, uremia, drugs having bone marrow suppressant properties such as chloramphenicol, and concurrent iron or folic acid deficiency
The short half-life of BPC-157 (less than 30 minutes) suggests frequent dosing might optimize tissue levels, yet the peptide initiates cellular processes that continue after clearance
REDEFINE clinical trial program: Safety and efficacy data
Non-small cell lung cancer accounts for the majority of all LCs more than 80% (it includes adenocarcinomas, large cell carcinomas and squamous cell carcinomas) [1, 2]
Amino acid concentrations are reported as molL 1
CJC-1295 and Ipamorelin are not FDA-approved medications, and are only appropriate for select patients following evaluation